Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Ordinary Shares, nominal value 0.00005 GBP per share
-
Shares outstanding
-
25.8B
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
21.3K
-
Shares change
-
+14.1K
-
Total reported value, excl. options
-
$28.1K
-
Value change
-
+$18.6K
-
Number of buys
-
4
-
Price
-
$1.32
Significant Holders of Biodexa Pharmaceuticals Plc - Ordinary Shares, nominal value 0.00005 GBP per share (BDRX) as of Q1 2025
6 filings reported holding BDRX - Biodexa Pharmaceuticals Plc - Ordinary Shares, nominal value 0.00005 GBP per share as of Q1 2025.
Biodexa Pharmaceuticals Plc - Ordinary Shares, nominal value 0.00005 GBP per share (BDRX) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.3K shares
of 25.8B outstanding shares and own 0% of the company stock.
Largest 6 shareholders include UBS Group AG (18.8K shares), GAMMA Investing LLC (1.43K shares), MORGAN STANLEY (700 shares), RHUMBLINE ADVISERS (315 shares), CONTRAVISORY INVESTMENT MANAGEMENT, INC. (40 shares), and SBI Securities Co., Ltd. (1 shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.